DYAI•benzinga•
Dyadic Receives Funding award From CEPI To Use C1 For Development Of Protein-Based Vaccines; CEPI Providing $4.5M To Non-Profit Fondazione Biotecnopolo di Siena For Proof-Of-Concept Research To Explore Producing Antigens In C1 Filamentous Fungus
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on March 20, 2025 by benzinga